IBio Analyst Ratings
IBio Analyst Ratings
While ratings are subjective and will change, the latest iBio (IBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price iBio (IBIO) is trading at is $0.87, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/16/2023 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 10/07/2022 | -80.45% | Cantor Fitzgerald | $2.5 → $0.17 | Downgrades | Overweight → Neutral |
| 11/29/2021 | 72.49% | JMP Securities | → $1.5 | Initiates Coverage On | → Outperform |
| 01/22/2021 | 244.99% | Cantor Fitzgerald | → $3 | Initiates Coverage On | → Overweight |
| 01/21/2021 | 244.99% | Cantor Fitzgerald | → $3 | Initiates Coverage On | → Overweight |
| 06/26/2020 | 216.24% | Alliance Global Partners | → $2.75 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/16/2023 | — | JMP 證券 | 降級 | 市場跑贏 → 市場表現 | |
| 2022 年 7 月 10 日 | -80.45% | 康托·菲茨杰拉德 | 2.5 美元 → 0.17 美元 | 降級 | 超重 → 中性 |
| 11/29/2021 | 72.49% | JMP 證券 | → 1.5 美元 | 啟動覆蓋範圍 | → 跑贏大市 |
| 2021 年 1 月 22 日 | 244.99% | 康托·菲茨杰拉德 | → 3 美元 | 啟動覆蓋範圍 | → 超重 |
| 2021 年 1 月 21 日 | 244.99% | 康托·菲茨杰拉德 | → 3 美元 | 啟動覆蓋範圍 | → 超重 |
| 2020 年 6 月 26 日 | 216.24% | 聯盟全球夥伴 | → 2.75 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for iBio (IBIO)?
智能生技 (IBIO) 的目標價格是多少？
The latest price target for iBio (AMEX: IBIO) was reported by JMP Securities on February 16, 2023. The analyst firm set a price target for $0.00 expecting IBIO to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
JMP 證券於 2023 年 2 月 16 日公布了智能生技（美國運通代碼：IBIO）的最新目標價格。該分析師公司將價格目標設定為 0.00 美元，預計 IBIO 將在 12 個月內跌至 12 個月內（下行可能為 -100.00％）。2 家分析師公司在去年報告了評級。
What is the most recent analyst rating for iBio (IBIO)?
iBIO（IBIO）的最新分析師評級是什麼？
The latest analyst rating for iBio (AMEX: IBIO) was provided by JMP Securities, and iBio downgraded their market perform rating.
iBio 的最新分析師評級（AMEX：IBIO）由 JMP 證券提供，iBio 降級了其市場表現評級。
When is the next analyst rating going to be posted or updated for iBio (IBIO)?
IBIO（IBIO）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iBio was filed on February 16, 2023 so you should expect the next rating to be made available sometime around February 16, 2024.
分析師在做廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 iBio 的高管和客戶交談，並聽取盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。對於 iBio 的最後一個評級被提交 2 月 16, 2023 所以你應該期望下一個評級將在二月左右的某個時候提供 16, 2024.
Is the Analyst Rating iBio (IBIO) correct?
分析師評級 iBIO（IBIO）是否正確？
While ratings are subjective and will change, the latest iBio (IBIO) rating was a downgraded with a price target of $0.00 to $0.00. The current price iBio (IBIO) is trading at is $0.87, which is out of the analyst's predicted range.
雖然評分是主觀的並且會發生變化，但最新的 iBIO（IBIO）評級降級，目標價格為 0.00 美元至 0.00 美元。目前的價格 IBIO（IBIO）的交易價格為 0.87 美元，超出了分析師的預測範圍。
